Federal award
TRANSPHORM, INC
W31P4Q21C0009
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $1,423,455.39
- Ceiling (potential value, not spending)
- $1,423,455.39
- Current value
- $1,423,455.39
- Gross positive obligations
- $1,423,455.39
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- TRANSPHORM, INC · CURGZRUXNHK3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- TRANSPHORM, INC · CURGZRUXNHK3
- Awarding agency
- Department of War · sub-agency 2100 · office W31P4Q
- Funding agency
- Department of War · sub-agency 97AE
- Product or service (PSC)
- AC32 · NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; APPLIED RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W31P4Q21C0009
- Award type code
- D
- Actions
- 10 · Sep 2, 2021 to Feb 28, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 28, 2025 | FY2025 | P00009 | B | $0.00 | — |
| Feb 26, 2024 | FY2024 | P00008 | B | $503,810.55 | — |
| Dec 15, 2023 | FY2024 | P00007 | B | $0.00 | — |
| Aug 15, 2023 | FY2023 | P00006 | B | $0.00 | — |
| Jun 20, 2023 | FY2023 | P00005 | M | $0.00 | — |
| May 17, 2023 | FY2023 | P00004 | B | $0.00 | — |
| Feb 24, 2023 | FY2023 | P00003 | B | $0.00 | — |
| May 16, 2022 | FY2022 | P00002 | C | $420,311.84 | — |
| May 9, 2022 | FY2022 | P00001 | B | $0.00 | — |
| Sep 2, 2021 | FY2021 | 0 | — | $499,333.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.